Cargando…
The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform
Despite an improved understanding of cancer molecular biology, immune landscapes, and advancements in cytotoxic, biologic, and immunologic anti-cancer therapeutics, cancer remains a leading cause of death worldwide. More than 8.2 million deaths were attributed to cancer in 2012, and it is anticipate...
Autores principales: | Schachtschneider, Kyle M., Schwind, Regina M., Newson, Jordan, Kinachtchouk, Nickolas, Rizko, Mark, Mendoza-Elias, Nasya, Grippo, Paul, Principe, Daniel R., Park, Alex, Overgaard, Nana H., Jungersen, Gregers, Garcia, Kelly D., Maker, Ajay V., Rund, Laurie A., Ozer, Howard, Gaba, Ron C., Schook, Lawrence B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572387/ https://www.ncbi.nlm.nih.gov/pubmed/28879168 http://dx.doi.org/10.3389/fonc.2017.00190 |
Ejemplares similares
-
Genetically Induced Tumors in the Oncopig Model Invoke an Antitumor Immune Response Dominated by Cytotoxic CD8β(+) T Cells and Differentiated γδ T Cells Alongside a Regulatory Response Mediated by FOXP3(+) T Cells and Immunoregulatory Molecules
por: Overgaard, Nana H., et al.
Publicado: (2018) -
Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas
por: Schachtschneider, Kyle M., et al.
Publicado: (2017) -
The Oncopig Cancer Model as a Complementary Tool for Phenotypic Drug Discovery
por: Segatto, Natalia V., et al.
Publicado: (2017) -
The Oncopig as an Emerging Model to Investigate Copper Regulation in Cancer
por: Carlson, Alyssa L., et al.
Publicado: (2022) -
Editorial: “Humanized” Large Animal Cancer Models: Accelerating Time and Effectiveness of Clinical Trials
por: Schachtschneider, Kyle M., et al.
Publicado: (2019)